Form D · Biotechnology
GenturaDx, Inc.
Hayward, CA · CIK 0001518477
Offering snapshot reported Apr 19, 2011 · SEC filing
- Reported sold
- $4.01M Offering amount: $19.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 4, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 19, 2011 | Initial | $4,006,452 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158646
Includes maximum principal amount of secured convertible promissory notes and purchase price for warrants
Secured convertible promissory notes, warrants to purchase Series C Preferred Stock, Qualified Financing Securities or other Financing Equity, underyling securities issuable upon conversion of notes and exercise of warrants and underlying Common Shares
Source: Form D, filed Apr 19, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Bagnall | Director, Executive |
| Jesus Ching | Director |
| Min Cui | Director |
| Joseph Tian | Director |
| Deborah Wright | Executive |
| Steven Yu | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
24590 Clawiter Road
Hayward, CA, 94545
Hayward, CA, 94545